review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1 |
P698 | PubMed publication ID | 9833774 |
P2093 | author name string | M Herlyn | |
E R Sauter | |||
P2860 | cites work | A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma | Q24307739 |
The cloning of a family of genes that encode the melanocortin receptors | Q24337156 | ||
Tumour progression and the nature of cancer | Q24683843 | ||
Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest | Q28270478 | ||
Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma | Q28270834 | ||
The melanoma antigen gene (MAGE) family is clustered in the chromosomal band Xq28 | Q28274173 | ||
Expression of MAGE genes in primary and metastatic cutaneous melanoma | Q28291687 | ||
Induction of nerve growth factor receptors on cultured human melanocytes | Q33633203 | ||
De novo expression of intercellular-adhesion molecule 1 in melanoma correlates with increased risk of metastasis | Q33832451 | ||
Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p. | Q34046828 | ||
Germline p16 mutations in familial melanoma | Q34059915 | ||
Growth factor receptor tyrosine kinases | Q34164164 | ||
Animal model for ultraviolet radiation-induced melanoma: platyfish-swordtail hybrid | Q34319781 | ||
Interleukin 1: the first interleukin. | Q34372820 | ||
A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma | Q34710725 | ||
Racial differences in melanoma incidence | Q36043285 | ||
Platelet-derived growth factor (PDGF) in oncogenesis: development of a vascular connective tissue stroma in xenotransplanted human melanoma producing PDGF-BB | Q36051073 | ||
Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas | Q36138681 | ||
The melanoma proteoglycan: restricted expression on microspikes, a specific microdomain of the cell surface | Q36215712 | ||
Class II histocompatibility antigen expression in human melanocytes transformed by Harvey murine sarcoma virus (Ha-MSV) and Kirsten MSV retroviruses | Q36353152 | ||
Increasing metastatic potential is associated with increasing genetic instability of clones isolated from murine neoplasms | Q36379155 | ||
Role of the alpha v beta 3 integrin in human melanoma cell invasion | Q36847392 | ||
Rashomon and the procrustean bed: a tale of dysplastic nevi | Q36912999 | ||
Interleukin 6: a fibroblast-derived growth inhibitor of human melanoma cells from early but not advanced stages of tumor progression | Q37228532 | ||
Human cutaneous malignant melanoma as a model for cancer | Q37253581 | ||
Human melanoma cell lines of primary and metastatic origin express the genes encoding the chains of platelet-derived growth factor (PDGF) and produce a PDGF-like growth factor | Q37400696 | ||
Identification of an amino acid sequence from the laminin A chain that stimulates metastasis and collagenase IV production | Q37721772 | ||
Structure, function, and clinical significance of human tumor antigens | Q38002574 | ||
Chromosomal and genetic alterations of 7,12-dimethylbenz[a]anthracene-induced melanoma from TP-ras transgenic mice | Q38503862 | ||
Transforming growth factor alpha | Q39517957 | ||
Melanoma antigens: immunological and biological characterization and clinical significance | Q39647325 | ||
Melanoma vaccines. Current status and future prospects | Q40389343 | ||
Antiantiidiotypic Response and Clinical Course of the Disease in Patients with Malignant Melanoma Immunized with Mouse Antiidiotypic Monoclonal Antibody MK2-23 | Q40433143 | ||
Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma | Q40694541 | ||
Molecular pathology of melanoma. | Q40894079 | ||
Restoration of CDKN2A into melanoma cells induces morphologic changes and reduction in growth rate but not anchorage-independent growth reversal | Q41102901 | ||
Identification of the S-Endo 1 endothelial-associated antigen | Q41240287 | ||
Recent advances in the care of the patient with malignant melanoma | Q41317571 | ||
UVR induction of TGF alpha: a possible autocrine mechanism for the epidermal melanocytic response and for promotion of epidermal carcinogenesis | Q41395179 | ||
Identification of a melanoma progression antigen as integrin VLA-2. | Q41696828 | ||
Mutational analysis of the human p53 gene in malignant melanoma | Q41697274 | ||
Tumorigenicity in human melanoma cell lines controlled by introduction of human chromosome 6. | Q41744430 | ||
Transformation of murine melanocytes by basic fibroblast growth factor cDNA and oncogenes and selective suppression of the transformed phenotype in a reconstituted cutaneous environment | Q41760172 | ||
Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation | Q41832676 | ||
Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine. | Q41969327 | ||
Serum-free culture of normal human melanocytes: growth kinetics and growth factor requirements | Q42493641 | ||
Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptides in vivo: implications for tumor vaccines with melanoma-associated antigens | Q42628260 | ||
Inhibition of metastases of a human melanoma xenograft by monoclonal antibody to the GD2/GD3 gangliosides | Q42818480 | ||
Differential stimulation of collagenase and chemotactic activity in fibroblasts derived from rat wound repair tissue and human skin by growth factors | Q43519248 | ||
Cytogenetics of human malignant melanoma and premalignant lesions | Q43722139 | ||
The differential expression of protein kinase C genes in normal human neonatal melanocytes and metastatic melanomas | Q44299372 | ||
Detection of Submicroscopic Lymph Node Metastases in Patients With Melanoma | Q44496865 | ||
Metastatic but not primary melanoma cell lines grow in vitro independently of exogenous growth factors | Q44864241 | ||
Monoclonal antibody against human tyrosinase and reactive with melanotic and amelanotic melanoma cells | Q44920555 | ||
Transformation of normal human melanocytes and non-malignant nevus cells by adenovirus 12-SV40 hybrid virus | Q45844902 | ||
Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells | Q48229182 | ||
Novel putative receptor tyrosine kinase encoded by the melanoma-inducing Tu locus in Xiphophorus | Q48284861 | ||
The Danish case-control study of cutaneous malignant melanoma. II. Importance of UV-light exposure | Q50548243 | ||
Loss of expression of the p16INK4/CDKN2 gene in cutaneous malignant melanoma correlates with tumor cell proliferation and invasive stage. | Q52526330 | ||
Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus | Q57269211 | ||
Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds | Q57948954 | ||
A study of adhesion molecules as markers of progression in malignant melanoma | Q58212505 | ||
Human melanoma-associated antigen p97 is structurally and functionally related to transferrin | Q59082088 | ||
Expression of cell adhesion molecules in human melanoma cell lines and their role in cytotoxicity mediated by tumor-infiltrating lymphocytes | Q67753695 | ||
Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report | Q68100559 | ||
Epidemiology and prognostic factors in malignant melanoma | Q68231681 | ||
Possible involvement of the chromosome region 10q24----q26 in early stages of melanocytic neoplasia | Q68519985 | ||
Suntan, sunburn, and pigmentation factors and the frequency of acquired melanocytic nevi in children. Similarities to melanoma: the Vancouver Mole Study | Q68799967 | ||
Characterization of melanoma-associated surface antigens involved in the adhesion and motility of human melanoma cells | Q68974066 | ||
Basic fibroblast growth factor is released from endothelial extracellular matrix in a biologically active form | Q69208934 | ||
Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients | Q69548004 | ||
Evidence for alpha-melanocyte-stimulating hormone (alpha-MSH) receptors on human malignant melanoma cells | Q69816562 | ||
Regulation of epidermal cell interleukin-6 production by UV light and corticosteroids | Q70124222 | ||
Constitutive expression of multiple growth factor genes by melanoma cells but not normal melanocytes | Q70199908 | ||
Tumor progression in human malignant melanoma: five stages defined by their antigenic phenotypes | Q70331960 | ||
Human melanoma cells but not normal melanocytes express vascular endothelial growth factor receptors | Q70575554 | ||
Spontaneous and induced differentiation of human melanoma cells | Q70670724 | ||
Differential patterns of HOX gene expression are associated with specific integrin and ICAM profiles in clonal populations isolated from a single human melanoma metastasis | Q71119402 | ||
Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside | Q72377535 | ||
Melanoma metastases from patients with hereditary cutaneous malignant melanoma contain a high frequency of N-ras activating mutations | Q72700938 | ||
The orderly progression of melanoma nodal metastases | Q72871409 | ||
Analysis of normal neoplastic human tissues for the tumor-associated protein p97 | Q72908863 | ||
Increase in radiation sensitivity of human malignant melanoma cells by expression of wild-type p16 gene | Q73212035 | ||
MELANOCYTE-STIMULATING HORMONE AND ADRENOCORTICOTROPHIC HORMONE. THEIR RELATION TO PIGMENTATION | Q76646253 | ||
New directions in research Ultraviolet light and skin cancer | Q85699460 | ||
P433 | issue | 3 | |
P921 | main subject | molecular biology | Q7202 |
P304 | page(s) | 132-143 | |
P577 | publication date | 1998-11-01 | |
P1433 | published in | Molecular Carcinogenesis | Q15724597 |
P1476 | title | Molecular biology of human melanoma development and progression | |
P478 | volume | 23 |
Q34658861 | A mediator of Rho-dependent invasion moonlights as a methionine salvage enzyme |
Q58450931 | Adhesion control of cyclin D1 and p27Kip1 levels is deregulated in melanoma cells through BRAF-MEK-ERK signaling |
Q36415915 | CXCL12/CXCR4 axis plays pivotal roles in the organ-specific metastasis of pancreatic adenocarcinoma: A clinical study |
Q38492340 | Chromosomal imbalances in primary and metastatic melanomas revealed by comparative genomic hybridization |
Q50335898 | Cooperation between STAT3 and c-jun suppresses Fas transcription. |
Q33895966 | Genetic and environmental melanoma models in fish |
Q40507438 | Involvement of overexpressed wild-type BRAF in the growth of malignant melanoma cell lines. |
Q38492729 | Liver metastatic ability of human melanoma cell line is associated with losses of chromosomes 4, 9p21-pter and 10p. |
Q39233170 | Mutant B-RAF regulates a Rac-dependent cadherin switch in melanoma |
Q34232481 | Recent advances in melanoma research |
Q42709078 | Role of SOCS-1 Gene on Melanoma Cell Growth and Tumor Development |
Q28211783 | Transduction of HOXD3-antisense into human melanoma cells results in decreased invasive and motile activities |
Search more.